Home » Topics » BioWorld Science

BioWorld Science
RSS

Updated data presented from phase Ib/II study of RG-6206 in boys with DMD

May 14, 2019

CAR fusion proteins targeting Strep-tagged peptides patented by Fred Hutchinson, TUM

May 14, 2019

Flavonoid promotes pleiotropic neuroprotective effects

May 14, 2019

IMVT-1401 demonstrates promising safety, PK and PD in healthy subjects

May 14, 2019

Long non-coding RNA CASC9 has an oncogenic role in breast cancer

May 14, 2019

Plasma kallikrein inhibitor VE-4840 shows preclinical potential for treating diabetic retinopathy

May 14, 2019

Voxelotor improves anemia in adolescents with sickle cell disease

May 14, 2019

Too much of a good thing foils heart repair

May 14, 2019

Gene Techno Science and OrthoRebirth collaborate to develop treatment for cleft lip/cleft palate

May 13, 2019

Wuhan Binhui initiates phase I study of OH-2 oncolytic viral therapy in solid tumors

May 13, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...